The White House has pulled the nomination of Dr. Heidi Overton to lead the Food and Drug Administration (FDA), citing lack of support to win Senate confirmation.

“Tonight, the White House abandoned a viable confirmation path for Dr. Overton. The WH said that this was because she did not have the votes to pass. This was odd as I was having productive conversations with members. I believe she would have had the votes to pass out of committee and pass the full Senate,” said Sen. Bill Cassidy (R-LA).

“My conversations with her convinced me she would follow the science and push back against decisions that put Americans’ health at risk. The last issue was that pro-life Senators sought final assurances from the Administration regarding the Administration’s commitment to life issues. The Administration withdrew Dr. Overton rather than make such commitments. Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats,” he continued.

POLITICO shared further:

But earlier Tuesday, Sen. Josh Hawley — a staunch abortion opponent who had questioned Overton sharply about the administration’s ongoing safety review of abortion pills — said he’d secured pledges from the nominee that satisfied him.

The White House didn’t immediately respond to a request for comment on Cassidy’s remarks.

ADVERTISEMENT

Axios first reported that Overton’s nomination would be pulled.

Leaders in the Make America Healthy Again movement, who had accused Overton of undermining their goals as a Trump aide, celebrated the nomination’s demise Tuesday night.

“God sent a rainbow after the storm,” Turning Point USA’s Alex Clark posted on X.

“Another one bites the dust,” said Vani Hari, an ally of Health Secretary Robert F. Kennedy Jr. who goes by “Food Babe” to her online followers.

Multiple Republican senators, including Sens. Susan Collins and Lisa Murkowski, said they were still undecided on Overton’s nomination.

“Many reporters who wrote about the White House backing off Heidi Overton for FDA commissioner claimed it stemmed from Cassidy’s backlash to an executive order about vaccines. This tweet makes it unambiguous that those stories were wrong. Calley Means revealed on the most popular podcast on the planet that Overton was at the center of half a dozen pay-to-play deals with Big Pharma and Big Ag! That should matter to the White House, and revoking her nomination could be a good sign,” Daily Caller News Foundation senior investigative reporter Emily Kopp wrote.

“The other swampier possibility — hinted at here — is that they pulled her nomination rather than ask FDA to produce a well-powered study on mifepristone, the abortion drug. That was a condition for confirmation for some senators,” she continued.

More from the Associated Press:

Currently, the FDA is conducting a safety review of the abortion pill mifepristone — at the request of Trump — that could reinstate restrictions on the drug’s use, including a requirement for in-person prescribing. FDA has promised a report on its safety findings by March.

ADVERTISEMENT

To win confirmation, Overton would have needed the votes of all 12 Republicans on the Senate Health, Education, Labor and Pensions Committee. Democrats hold 11 seats. Without support of the committee, Overton faced little chance of winning a full Senate vote on the chamber floor.

Republicans have been racing to try to confirm Trump’s nominees before handing over power to Senate Democrats in January.

It was not immediately clear when, or if, the White House might put forward another nominee.

Cassidy has repeatedly tried to win commitments on upholding vaccine standards, including from Kennedy, by threatening to withhold his vote. Ultimately, though, he voted in favor of each nominee that came before his committee.

Other Republicans, including Maine Sen. Susan Collins, raised concerns about other health issues, including Overton’s approach to flavored e-cigarettes. The FDA recently authorized the first fruit-flavored e-cigarettes for adult smokers looking to quit. Under previous administrations, including the first Trump administration, the agency had opposed vaping flavors that could attract teens and children.

 

Join The Conversation. Leave a Comment.